News Focus
News Focus
Followers 75
Posts 7728
Boards Moderated 0
Alias Born 05/01/2011

Re: SovereignNinja5 post# 446414

Tuesday, 03/03/2026 1:06:29 PM

Tuesday, March 03, 2026 1:06:29 PM

Post# of 447903
I still don't understand why, if this is such a seismic development for Amarin, management has said literally nothing about it.

Is there a reason to stay utterly silent on this. Prior management certainly talked about the combo pill...

Incidentally, I checked the Recordati agreement -- it appears to cover any new "formulation"...

1.48“Licensed Product” means the pharmaceutical product marketed under the trade name Vazkepa® and other associated Trademarks containing or comprising the compound Icosapent ethyl in any present or future finished form presentations (including all dosage forms, formulations, dosage strengths and packaging configurations).


"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News